TrialClinical pharmacokinetics2022

Safety, Pharmacodynamics, and Pharmacokinetics of P2X3 Receptor Antagonist Eliapixant (BAY 1817080) in Healthy Subjects: Double-Blind Randomized Study.

Christian Friedrich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.